Psychiatry and Neurology, Neurology · Fountain Valley, CA
NPI
1992720916
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9940 Talbert Ave Ste 204
Fountain Valley, CA, 92708
Phone (714) 378-5062
Groups this clinician bills Medicare through
Medicare paid, 2024
$381K
41,470 services
Medicare patients, 2024
280
Average age 74
Drug cost, 2024
$4.3M
5,142 prescriptions
Company payments, 2025
$8,314
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel D Truong was code J0585 (injection, onabotulinumtoxina, 1 unit), 18,340 times for 56 patients. In total Daniel D Truong billed 41,470 services in 23 codes, and Medicare paid $381K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 18,340 | 56 | $4.87 | $89K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 13,594 | 32 | $4.03 | $55K |
| J0586 Injection, abobotulinumtoxina, 5 units | Office | 6,601 | 18 | $6.80 | $45K |
| J0587 Injection, rimabotulinumtoxinb, 100 units | Office | 1,425 | 20 | $9.61 | $14K |
| 99214 Office E&M - Established | Office | 812 | 246 | $106.12 | $86K |
| 95874 Musculoskeletal | Office | 145 | 47 | $69.96 | $10K |
| 64612 Musculoskeletal | Office | 133 | 41 | $152.08 | $20K |
| 64616 Musculoskeletal | Office | 105 | 37 | $161.61 | $17K |
| 31570 Other Organ Systems | Office | 60 | 23 | $299.82 | $18K |
| 99204 Office E&M - New | Office | 54 | 54 | $139.05 | $7,508 |
| 76942 Ultrasound - Nonspecific | Office | 44 | 22 | $50.84 | $2,237 |
| 64611 Musculoskeletal | Office | 44 | 21 | $116.53 | $5,127 |
| 11105 Skin Biopsy | Office | 40 | 20 | $53.74 | $2,150 |
| 11104 Skin Biopsy | Office | 20 | 20 | $111.31 | $2,226 |
By year: 2022 $358K for 39,547 services; 2023 $353K for 39,943 services; 2024 $381K for 41,470 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel D Truong prescribed most often to Medicare patients was Rytary (Carbidopa/Levodopa), with 1,031 prescriptions and refills. In total Daniel D Truong wrote 5,142 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rytary Carbidopa/Levodopa | 1,031 | 1,266 | 103 | $836K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 697 | 1,038 | 150 | $16K |
| Clonazepam Generic | 530 | 656 | 111 | $2,713 |
| Rasagiline Mesylate Generic | 336 | 626 | 67 | $70K |
| Linzess Linaclotide | 296 | 387 | 72 | $202K |
| Entacapone Generic | 204 | 334 | 44 | $34K |
| Nuplazid Pimavanserin Tartrate | 176 | 187 | 24 | $922K |
| Lactulose Generic | 157 | 171 | 47 | $3,183 |
| Gocovri Amantadine Hcl | 123 | 139 | 18 | $448K |
| Dhivy Carbidopa/Levodopa | 113 | 136 | 20 | $73K |
| Neupro Rotigotine | 107 | 137 | 22 | $112K |
| Xadago Safinamide Mesylate | 107 | 140 | 19 | $156K |
| Donepezil Hcl Generic | 88 | 140 | 15 | $607 |
| Droxidopa Generic | 72 | 76 | Under 11 | $364K |
| Nourianz Istradefylline | 63 | 83 | 11 | $152K |
Brand drugs: 2,461 claims; generic drugs: 2,681 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel D Truong $8,314 ($8,314 in general payments such as food, travel and fees) from 37 companies. The largest payer was Ipsen Innovation with $1,888.
| Company | Payments | Amount |
|---|---|---|
| Ipsen Innovation IPN.PA | 3 | $1,888 |
| Amneal Pharmaceuticals LLC AMRX | 13 | $1,447 |
| Abbvie Inc. ABBV | 52 | $1,110 |
| UCB, Inc. UCB.BR | 27 | $631 |
| ACADIA Pharmaceuticals Inc ACAD | 18 | $428 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 13 | $321 |
| Merz Pharmaceuticals, LLC | 12 | $289 |
| Neurocrine BioSciences, Inc. NBIX | 11 | $265 |
| SK Life Science, Inc. | 11 | $239 |
| Eisai Inc. 4523.T | 9 | $195 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.